Fabrinet (FN)
Last Price$193.85.5%
Market Cap$7,009.5M
FN Rating
FN Quality rating performance
FN Intrinsic Value
Key Highlights:
As of Mar 07, 2025 FN Relative Value is $296.2, which is undervalued by 52.8%, compared to current share price of $193.8.
As of Mar 07, 2025 FN DCF Value is $154.3, which is overvalued by 20.4%, compared to current share price of $193.8.
FN Share Price History
1W (3.1%)
1M (8.6%)
6M (7.7%)
YTD 2.5%
1Y (12.0%)
3Y 105.0%
5Y 260.5%
10Y 958.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
FN Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$7,009.5M
$6,080.9M
$3,122.6M
$314.2M
Shares Outstanding
36M
Employees
N/A
Growth (CAGR)
13.9%
19.0%
22.93%
24.4%
14.5%
23.46%
Profitability
12.3%
9.6%
10.4%
12.3%
10.1%
96.4%
Intrinsic Value
$224.6 (15.9% undervalued)
$153.5
$295.8
$160.3
$235.4
40.4%
Return on Capital
Financial Health
($928.5M)
(3.0x)
7,006.8x
Dividends
Earnings
May 05, 2025
BEAT by 4.2%
BEAT by 0.4%
(3.6%)
10 Beat & null Miss
FN Stock Financials
FN Income Statement Metrics
Annual
Quarterly
LTM
FN Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$413.1M +93.7% YoY
Capital Expenditure (CAPEX)
($48.4M) -22.2% YoY
Free Cash Flow (FCF)
$364.7M +141.5% YoY
FN Income Statement Overview
Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
$2,883.0M 9.0% YoY
Cost of revenue
$2,526.8M 9.4% YoY
Pre-tax income
$311.4M 19.7% YoY
10.8% margin
FN Balance Sheet Overview
Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
Assets
Liabilities
Total assets
$2,338.5M
Current assets ($2,012.7M, 86.1% of total)
$858.6M (36.7%)
$592.5M (25.3%)
Other current assets
$561.6M (24.0%)
Non-current assets ($325.8M, 13.9% of total)
$0.0 (0.0%)
$312.6M (13.4%)
$2,321.0K (0.1%)
Other non-current assets
$10.9M (0.5%)
Financial position
($852.3M)
Cash & Short-term
Investments
Total Debt
FN Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FN Earnings Surprises
Crunching data... Almost there!
FN Dividends
FN Dividend Yield
Crunching data... Almost there!
FN Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with FN
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$7,009.5M | 6.7 | $224.6 15.9% undervalued | (12.0%) | $3,122.6M | $314.2M | 14.8% | 10.1% | 12.3% | 28.8% | 0.3% | |
$79.7B | 7.3 | $80.2 27.5% undervalued | 14.0% | $15.2B | $2,149.3M | 21.3% | 14.1% | 33.8% | 19.6% | 4.1% | |
$45.1B | 6.5 | $189.9 25.9% undervalued | 7.2% | $15.9B | $2,902.0M | (1.1%) | 18.3% | 34.7% | 16.6% | 33.6% | |
$42.1B | 7.1 | $173.7 20.8% overvalued | 57.8% | $6,296.9M | $839.7M | 20.4% | 13.3% | 58.7% | 31.0% | 1.7% | |
$40.5B | 6.3 | $37.4 18.6% overvalued | 43.8% | $13.1B | $974.0M | 4.2% | 7.4% | 32.3% | 6.3% | 65.1% | |
$27.1B | 6.2 | $128.0 17.9% overvalued | (0.9%) | $3,720.0M | $995.0M | (30.4%) | 26.7% | 62.2% | 8.6% | 38.9% | |
$26.4B | 6.1 | $83.4 8.9% undervalued | (9.6%) | $6,231.8M | $1,406.4M | 14.8% | 22.6% | 59.9% | 6.7% | 36.4% | |
$22.6B | 7.1 | $414.2 14.2% overvalued | 12.8% | $5,669.3M | $1,108.2M | 0.6% | 19.5% | 42.1% | 6.9% | 27.7% | |
$17.0B | 6.2 | $50.4 27.0% overvalued | 10.5% | $3,683.3M | $497.8M | (3.0%) | 13.5% | 64.9% | (0.4%) | 26.4% | |
$15.8B | 6.3 | $503.0 259.4% undervalued | (9.2%) | $27.5B | $1,084.0M | (17.8%) | 3.9% | 9.1% | 11.9% | 211.7% | |
$13.4B | 6.4 | $87.0 150.7% undervalued | 13.7% | $23.9B | $1,347.3M | (18.6%) | 5.6% | 8.3% | 14.6% | 20.2% |
FAQ
What is Fabrinet (FN) stock rating?
As of today, Fabrinet has a stock rating of 7 (out of 10), which is considered Good.
is Fabrinet (FN) a good stock to buy?
As of today, Fabrinet has a Good stock rating, which is 15.9% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.